Planchard, D., Jänne, P., Cheng, Y., Yang, J., Yanagitani, N., Kim, S., . . . Kobayashi, K. (2023). Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
Citación estilo ChicagoPlanchard, D., et al. Osimertinib With or Without Chemotherapy in EGFR-Mutated Advanced NSCLC. 2023.
Cita MLAPlanchard, D., et al. Osimertinib With or Without Chemotherapy in EGFR-Mutated Advanced NSCLC. 2023.
Precaución: Estas citas no son 100% exactas.
